Species Difference in the Metabolism of Mulberrin in Vitro and Its Inhibitory Effect on Cytochrome P450 and UDP-Glucuronosyltransferase Enzymes

被引:1
|
作者
Hu, Jiayin [1 ]
Hu, Tingting [1 ]
Guo, Zhe [1 ]
Song, Yonggui [2 ]
Shan, Lina [1 ]
Shi, Xianbao [1 ]
机构
[1] Jinzhou Med Univ, Affiliated Hosp 1, Jinzhou 121001, Peoples R China
[2] Jiangxi Univ Tradit Chinese Med, 1688 Meiling Rd, Nanchang 330006, Peoples R China
关键词
CYP; uridine 5'-diphosphate (UDP)-glucuronosyltransferase; liver microsome; interspecies dif-ference; mulberrin; Western blot analysis; DRUG-DRUG INTERACTIONS; HUMAN LIVER-MICROSOMES; HEPATIC-CLEARANCE; CANCER; GLUCURONIDATION; CYP3A4; UGT; IDENTIFICATION; CONSTITUENTS; PREVALENCE;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
This study aimed to evaluate the interspecies difference in metabolism of mulberrin and examine the interaction between mulberrin and CYP enzymes or recombinant human uridine 5'-diphosphate (UDP)minipig (PLMs), monkey (MLMs), rabbit (RLMs), rat (RAMs), and mouse (MIMs) were used to investigate metabolic diversity among different species. Additionally, recombinant human supersomes were used to confirm that metabolic enzymes are involved in the biotransformation of mulberrin. We also evaluated the influence of mulberrin on protein expression by Western blot analysis. Mulberrin metabolism showed significant interspecies differences. We found four and two metabolites in phase I and II reaction systems, respectively. In phase I metabolism profiles of mulberrin for HLMs, PLMs and MLMs conformed to the classic Michaelis-Menten kinetics, RAMs and MIMs followed biphasic kinetics; phase II reaction of mulberrin in HLMs, DLMs, PLMs, MLMs, RLMs, RAMs and MIMs followed biphasic kinetics. UGT1A1 were the major CYP isoforms responsible for the metabolism of mulberrin. Mulberrin showed potent inhibitory effects against CYP3A4, CYP2C9, CYP2E1, UGT1A1, UGT1A3 and UGT2B7 with IC50 values of 54.21, 9.93, 39.12, 3.84, 2.01, 16.36 mu M, respectively. According to Western blot analysis, mulberrin can upregulate the protein expression of CYP2C19, and downregulate the expression levels of CYP3A5 and CYP2C9 in HepG2 cells as concentration increased. The interspecies comparisons can help find other species with metabolic pathways similar to those in humans for future in vivo studies.
引用
收藏
页码:669 / 678
页数:10
相关论文
共 50 条
  • [41] Mangifera indica L. Extract and Mangiferin Modulate Cytochrome P450 and UDP-Glucuronosyltransferase Enzymes in Primary Cultures of Human Hepatocytes
    Rodeiro, Idania
    Jose Gomez-Lechon, M.
    Perez, Gabriela
    Hernandez, Ivones
    Alfredo Herrera, Jose
    Delgado, Rene
    Castell, Jose V.
    Teresa Donato, M.
    PHYTOTHERAPY RESEARCH, 2013, 27 (05) : 745 - 752
  • [42] The role of cytochrome P450 enzymes In metabolism of acrylamide in vitro
    Tomalik-Scharte, D.
    Rokitta, D.
    Fuhr, U.
    Kunz, D.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2011, 383 : 97 - 97
  • [43] Role of cytochrome P450 enzymes in fimasartan metabolism in vitro
    Choi, Young Jae
    Lee, Ji-Yoon
    Ryu, Chang Seon
    Ha Chi, Yong
    Paik, Soo Heui
    Kim, Sang Kyum
    FOOD AND CHEMICAL TOXICOLOGY, 2018, 115 : 375 - 384
  • [44] In vitro differences in toddalolactone metabolism in various species and its effect on cytochrome P450 expression
    Shan, Lina
    Shi, Xianbao
    Hu, Tingting
    Hu, Jiayin
    Guo, Zhe
    Song, Yonggui
    Su, Dan
    Zhang, Xiaoyong
    PHARMACEUTICAL BIOLOGY, 2022, 60 (01) : 1591 - 1605
  • [45] Renal drug metabolism in humans: the potential for drug-endobiotic interactions involving cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT)
    Knights, Kathleen M.
    Rowland, Andrew
    Miners, John O.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 76 (04) : 587 - 602
  • [46] A CHARACTERIZATION OF BICTEGRAVIR'S METABOLISM THROUGH GLUCURONOSYLTRANSFERASE AND CYTOCHROME P450 ENZYMES.
    Raviele, A.
    Lu, J.
    Desta, Z.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S90 - S90
  • [47] The role of human cytochrome P450 enzymes in metabolism of acrylamide in vitro
    Kraus, Daria
    Rokitta, Dennis
    Fuhr, Uwe
    Tomalik-Scharte, Dorota
    TOXICOLOGY MECHANISMS AND METHODS, 2013, 23 (05) : 346 - 351
  • [48] Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of rosiglitazone
    Baldwin, SJ
    Clarke, SE
    Chenery, RJ
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 48 (03) : 424 - 432
  • [49] In vitro metabolism of mirtazapine enantiomers by human cytochrome P450 enzymes
    Dodd, S
    Boulton, DW
    Burrows, GD
    DeVane, CL
    Norman, TR
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2001, 16 (07) : 541 - 544
  • [50] Age-related changes in mRNA levels of hepatic transporters, cytochrome P450 and UDP-glucuronosyltransferase in female rats
    Atsushi Kawase
    Ayami Ito
    Ayano Yamada
    Masahiro Iwaki
    European Journal of Drug Metabolism and Pharmacokinetics, 2015, 40 : 239 - 244